While insider sells can often raise red flags for investors, the context of these transactions is crucial. In the case of Krista Davis's recent sell of ANI Pharmaceuticals Inc shares, the activity appears to be part of a broader pattern of insider selling at the company. Despite the high price-earnings ratio, the stock's GF Value suggests that it is fairly valued. Investors should consider these factors, along with their own research and investment goals, when making decisions about ANI Pharmaceuticals Inc. As always, insider trading is just one piece of the puzzle when evaluating a stock's potential.